Change in the acterial flora of pouchitis

Hepato-Gastroenterology

Volumn 53, Issue 67, 2006, Pages 55-59

  Iwaya, Akira ^a   Iiai, Tsuneo ^a   Okamoto, Haruhiko ^a   Ajioka, Yoichi ^a   Yamamoto, Tatsuo ^a   Asahara, Takashi ^b   Nomoto, Koji ^b   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Bacterial flora; Heal pouch anal anastomosis; Pouchitis; Ulcerative colitis

Indexed keywords

ADULT; ANASTOMOSIS; ARTICLE; BACTERIAL FLORA; BIFIDOBACTERIUM; CLINICAL ARTICLE; CONTROLLED STUDY; FECES ANALYSIS; FECES CULTURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; LACTOBACILLUS; MALE; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; PROCTOCOLECTOMY; SCORING SYSTEM; ULCERATIVE COLITIS; ANAEROBIC BACTERIUM; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED;

BACTERIA, ANAEROBIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POUCHITIS;

EID: 33344462428     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Stahlberg D, Gullberg K, Liljeqvist L, Hellers G, Lofberg R: Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996; 39:1012-1018.
2. Keranen U, Luukkonen P, Jarvinen H: Functional results after restorative proctocolectomy complicated by pouchitis. Dis Colon Rectum 1997; 40:764-769.
3. Heuschen UA, Autschbach F, Allemeyer EH, Zollinger AM, Keuschen G, Uehlein T, Herfarth C, Stern J: Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 2001; 44:487-499.
4. Kuhbacher T, Schreiber S, Runkel N: Pouchitis: pathophysiology and treatment. Int J Colorectal Dis 1998; 13:196-207.
5. Gionchetti P, Amadini C, Rizzello F, Venturi A, Poggioli G, Campieri M: Diagnosis and treatment of pouchitis. Best Pract Res Clin Gastroenterol 2003; 17:75-87.
6. Shen B, Achkar JP, Connor JT, Ormsby AH, Remzi FH, Bevins CL, Brzezinski A, Bambrick ML, Fazio VW, Lashner BA: Modified pouchitis disease activity index:a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003; 46:748-753.
7. Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Bevins CL, Brzezinski A, Petras RE: Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121:261-267.
8. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF: Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994; 69:409-415.
9. Nicholls RJ, Banerjee AK: Pouchitis: risk factors, etiology, and treatment. World J Surg 1998; 22:347-351.
10. Gionchetti P, Rizzello F, Venturi A, Ugolini F, Rossi M, Brigidi P, Johansson R, Ferrieri A, Poggioli G, Campieri M: Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999; 13:713-718.
11. Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Brzezinski A, Bevins CL, Bambrick ML, Seidner DL, Fazio VW: A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001; 7:301-305.
12. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119:305-309.
13. Azuma R, Suto T: Validity of transfer of the taxonomical position of Corynebacterium pseudopyogenes from genus Corynebacterium to genus Actinomyces. In: Izuka H, Hasegawa T, (Eds.). Proceeding of the first international conference on culture collection. Tokyo: University of Tokyo Press; 1970; pp. 493-505.
14. Tanaka R, Mutai M: Improved medium for selective isolation and enumeration of Bifidobacterium. Appl Env Microbiol 1980; 40:866-869.
15. Petts DN: Colistin-oxolinic acid-blood agar: a new selective medium for streptococci. J Clin Microbiol 1984; 19:4-7.
16. Asahara T, Nomoto K, Shimizu K, Watanuki M, Tanaka R: Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharide. J Appl Microbiol 2001; 91:985-996.
17. Santavirta J, Mattila J, Kokki M, Matikainen M: Mucosal morphology and faecal bacteriology after ileoanal anastomosis. Int J Colorectal Dis 1991; 6:38-41.
18. Ruseler-van Embden JG, Scheuten WR, van Lieshout LM: Pouchitis: result of microbial imbalance? Gut 1994; 35:658-664.
19. Luukkonen P, Valtonen V, Sivonen A, Sipponen P, Jarvinen H: Fecal bacteriology and reservoir ileitis in patients operated on for ulcerative colitis. Dis Colon Rectum 1988; 31:864-867.
20. Kmiot WA, Youngs D, Tudor R, Thompson H, Keighley MR: Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis. Br J Surg 1993; 80:l445-1449.
21. Nygaard K, Bergan T, Bjorneklett A, Hoverstad T, Lassen J, Aase S: Topical metronidazole treatment in pouchitis. Scand J Gastroenterol 1994; 29:462-467.
22. Sagar PM, Taylor BA, Godwin P, Holdsworth PJ, Johnston D, Lewis W, Miller A, Quirke P, Williamson M: Acute pouchitis and deficiencies of fuel. Dis Colon Rectum 1995; 38:488-493.
23. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Rossi SS, Hofmann AF, Gores GJ, Phillips SF: Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995; 40:1474-1483.
24. Wells CL, Maddaus MA, Jechorek RP, Simmons RL: Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis 1988; 7:107-113.
25. Simon GL, Gorbach SL: Intestinal flora in health and disease. Gastroenterology 1984; 86:174-193.
26. Gibson GR, Roberfroid MB: Dietary modulation of the human colonie microbiota: introducing the concept of prebiotics. J Nutr 1995; 125:1401-1412.
27. Borruel N, Carol M, Casellas F, Antolin M, de Lara F, Espin E, Naval J, Guarner F, Malagelada JR: Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002; 51:659-664.
28. Tvede M, Rask-Madsen J: Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1:1156-1160.
29. Salminen S, Salminen E: Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol 1997; 222:45-48.
30. Orrhage K, Nord CE: Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res 2000; 26:95-111.
31. Fabia R, Ar'Rajab A, Johansson ML, Andersson R, Willen R, Jeppsson B, Molin G, Bengmark S: Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 1993; 54:248-255.
32. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M: Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997; 76:101-107.
33. Yuki N, Watanabe K, Mike A, Tagami Y, Tanaka R, Ohwaki M, Morotomi M: Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies. Int J Food Microbiol 1999; 48:51-57.